{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T01:25:49Z","timestamp":1792891549535,"version":"4.5.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T00:00:00Z","timestamp":1742428800000},"content-version":"vor","delay-in-days":19,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Avadel Pharmaceuticals"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CNS Drugs"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1007\/s40263-024-01142-8","type":"journal-article","created":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T00:31:49Z","timestamp":1742517109000},"page":"23-36","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["A Survey of People Living with Narcolepsy in the USA: Path to Diagnosis, Quality of Life, and Treatment Landscape from the Patient\u2019s Perspective"],"prefix":"10.1007","volume":"39","author":[{"given":"Luis E.","family":"Ortiz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Marie","family":"Morse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lois","family":"Krahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maggie","family":"Lavender","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Horsnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dianna","family":"Cronin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7375-5020","authenticated-orcid":false,"given":"Jennifer","family":"Gudeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,20]]},"reference":[{"key":"1142_CR1","doi-asserted-by":"crossref","first-page":"16100","DOI":"10.1038\/nrdp.2016.100","volume":"3","author":"BR Kornum","year":"2017","unstructured":"Kornum BR, Knudsen S, Ollila HM, et al. Narcolepsy. Nat Rev Dis Primers. 2017;3:16100.","journal-title":"Nat Rev Dis Primers"},{"key":"1142_CR2","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/sleep\/9.1.205","volume":"9","author":"R Broughton","year":"1986","unstructured":"Broughton R, Valley V, Aguirre M, et al. Excessive daytime sleepiness and the pathophysiology of narcolepsy-cataplexy: a laboratory perspective. Sleep. 1986;9:205\u201315.","journal-title":"Sleep"},{"key":"1142_CR3","doi-asserted-by":"crossref","DOI":"10.1111\/jsr.13210","volume":"30","author":"TE Weaver","year":"2021","unstructured":"Weaver TE, Mathias SD, Crosby RD, et al. Relationship between sleep efficacy endpoints and measures of functional status and health-related quality of life in participants with narcolepsy or obstructive sleep apnea treated for excessive daytime sleepiness. J Sleep Res. 2021;30: e13210.","journal-title":"J Sleep Res"},{"key":"1142_CR4","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jsmc.2016.10.001","volume":"12","author":"M Thorpy","year":"2017","unstructured":"Thorpy M, Morse AM. Reducing the clinical and socioeconomic burden of narcolepsy by earlier diagnosis and effective treatment. Sleep Med Clin. 2017;12:61\u201371.","journal-title":"Sleep Med Clin"},{"key":"1142_CR5","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2147\/NSS.S103467","volume":"9","author":"VC Abad","year":"2017","unstructured":"Abad VC, Guilleminault C. New developments in the management of narcolepsy. Nat Sci Sleep. 2017;9:39\u201357.","journal-title":"Nat Sci Sleep."},{"key":"1142_CR6","volume-title":"The voice of the patient: narcolepsy","author":"Center for Drug Evaluation and Research (CDER)","year":"2014","unstructured":"Center for Drug Evaluation and Research (CDER). The voice of the patient: narcolepsy. Silver Spring: US Food and Drug Administration; 2014."},{"key":"1142_CR7","doi-asserted-by":"crossref","first-page":"959","DOI":"10.3949\/ccjm.85a.17086","volume":"85","author":"EC Golden","year":"2018","unstructured":"Golden EC, Lipford MC. Narcolepsy: diagnosis and management. Cleve Clin J Med. 2018;85:959\u201369.","journal-title":"Cleve Clin J Med"},{"key":"1142_CR8","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.genhosppsych.2009.08.007","volume":"32","author":"HA Fortuyn","year":"2010","unstructured":"Fortuyn HA, Lappenschaar MA, Furer JW, et al. Anxiety and mood disorders in narcolepsy: a case-control study. Gen Hosp Psychiatry. 2010;32:49\u201356.","journal-title":"Gen Hosp Psychiatry"},{"key":"1142_CR9","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.sleep.2011.01.013","volume":"12","author":"HA Fortuyn","year":"2011","unstructured":"Fortuyn HA, Mulders PC, Renier WO, et al. Narcolepsy and psychiatry: an evolving association of increasing interest. Sleep Med. 2011;12:714\u20139.","journal-title":"Sleep Med"},{"key":"1142_CR10","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.sleep.2021.06.008","volume":"84","author":"MM Ohayon","year":"2021","unstructured":"Ohayon MM, Thorpy MJ, Carls G, et al. The Nexus Narcolepsy Registry: methodology, study population characteristics, and patterns and predictors of narcolepsy diagnosis. Sleep Med. 2021;84:405\u201314.","journal-title":"Sleep Med"},{"key":"1142_CR11","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.sleep.2009.02.009","volume":"11","author":"G Sansa","year":"2010","unstructured":"Sansa G, Iranzo A, Santamaria J. Obstructive sleep apnea in narcolepsy. Sleep Med. 2010;11:93\u20135.","journal-title":"Sleep Med"},{"key":"1142_CR12","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3810\/pgm.2014.01.2727","volume":"126","author":"R Rosenberg","year":"2014","unstructured":"Rosenberg R, Kim AY. The AWAKEN survey: knowledge of narcolepsy among physicians and the general population. Postgrad Med. 2014;126:78\u201386.","journal-title":"Postgrad Med"},{"key":"1142_CR13","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.sleep.2011.07.001","volume":"12","author":"JA Mindell","year":"2011","unstructured":"Mindell JA, Bartle A, Wahab NA, et al. Sleep education in medical school curriculum: a glimpse across countries. Sleep Med. 2011;12:928\u201331.","journal-title":"Sleep Med"},{"key":"1142_CR14","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1212\/WNL.57.11.2029","volume":"57","author":"Y Dauvilliers","year":"2001","unstructured":"Dauvilliers Y, Montplaisir J, Molinari N, et al. Age at onset of narcolepsy in two large populations of patients in France and Quebec. Neurology. 2001;57:2029\u201333.","journal-title":"Neurology"},{"key":"1142_CR15","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.sleep.2010.05.010","volume":"12","author":"S Overeem","year":"2011","unstructured":"Overeem S, van Nues SJ, van der Zande WL, et al. The clinical features of cataplexy: a questionnaire study in narcolepsy patients with and without hypocretin-1 deficiency. Sleep Med. 2011;12:12\u20138.","journal-title":"Sleep Med"},{"key":"1142_CR16","unstructured":"Jazz Pharmaceuticals Inc. Xyrem\u2122 (sodium oxybate oral solution, CIII). Full Prescribing Information. Palo Alto, CA: Jazz Pharmaceuticals; 2023."},{"key":"1142_CR17","unstructured":"Jazz Pharmaceuticals. Xywav\u2122 (calcium, magnesium, potassium, and sodium oxybate). Full Prescribing Information. Palo Alto, CA: Jazz Pharmaceuticals, Inc; 2023."},{"key":"1142_CR18","unstructured":"Avadel Pharmaceuticals. LUMRYZ\u2122 (sodium oxybate for extended-release oral suspension, CIII). Full Prescribing Information. Chesterfield, MO: Avadel Pharmaceuticals; 2024."},{"key":"1142_CR19","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.sleep.2020.02.013","volume":"70","author":"L P\u00e9rez-Carbonell","year":"2020","unstructured":"P\u00e9rez-Carbonell L, Lyons E, Gnoni V, et al. Adherence to wakefulness promoting medication in patients with narcolepsy. Sleep Med. 2020;70:50\u20134.","journal-title":"Sleep Med"},{"key":"1142_CR20","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.sleep.2019.09.001","volume":"68","author":"MJ Thorpy","year":"2020","unstructured":"Thorpy MJ, Bogan RK. Update on the pharmacologic management of narcolepsy: mechanisms of action and clinical implications. Sleep Med. 2020;68:97\u2013109.","journal-title":"Sleep Med"},{"key":"1142_CR21","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.sleep.2014.10.002","volume":"16","author":"MJ Thorpy","year":"2015","unstructured":"Thorpy MJ, Dauvilliers Y. Clinical and practical considerations in the pharmacologic management of narcolepsy. Sleep Med. 2015;16:9\u201318.","journal-title":"Sleep Med"},{"key":"1142_CR22","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1093\/sleep\/16.3.203","volume":"16","author":"MM Mitler","year":"1993","unstructured":"Mitler MM, Hajdukovic R, Erman MK. Treatment of narcolepsy with methamphetamine. Sleep. 1993;16:306\u201317.","journal-title":"Sleep"},{"key":"1142_CR23","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.neulet.2008.03.076","volume":"437","author":"K Blazejova","year":"2008","unstructured":"Blazejova K, Illnerova H, Hajek I, Nevsimalova S. Circadian rhythm in salivary melatonin in narcoleptic patients. Neurosci Lett. 2008;437:162\u20134.","journal-title":"Neurosci Lett"},{"key":"1142_CR24","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0196-9781(80)90003-0","volume":"1","author":"S Pavel","year":"1980","unstructured":"Pavel S, Goldstein R, Petrescu M. Vasotocin, melatonin and narcolepsy: possible involvement of the pineal gland in its patho-physiological mechanism. Peptides. 1980;1:281\u20134.","journal-title":"Peptides"},{"key":"1142_CR25","first-page":"557","volume":"4","author":"M Billiard","year":"2008","unstructured":"Billiard M. Narcolepsy: current treatment options and future approaches. Neuropsychiatr Dis Treat. 2008;4:557\u201366.","journal-title":"Neuropsychiatr Dis Treat"},{"key":"1142_CR26","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S1389-9457(03)00072-8","volume":"4","author":"BF Boeve","year":"2003","unstructured":"Boeve BF, Silber MH, Ferman TJ. Melatonin for treatment of REM sleep behavior disorder in neurologic disorders: results in 14 patients. Sleep Med. 2003;4:281\u20134.","journal-title":"Sleep Med"},{"key":"1142_CR27","doi-asserted-by":"crossref","first-page":"275","DOI":"10.5664\/jcsm.6462","volume":"13","author":"LA Erland","year":"2017","unstructured":"Erland LA, Saxena PK. Melatonin natural health products and supplements: presence of serotonin and significant variability of melatonin content. J Clin Sleep Med. 2017;13:275\u201381.","journal-title":"J Clin Sleep Med"},{"key":"1142_CR28","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.5664\/jcsm.9328","volume":"17","author":"K Maski","year":"2021","unstructured":"Maski K, Trotti LM, Kotagal S, et al. Treatment of central disorders of hypersomnolence: an American Academy of Sleep Medicine clinical practice guideline. J Clin Sleep Med. 2021;17:1881\u201393.","journal-title":"J Clin Sleep Med"},{"key":"1142_CR29","doi-asserted-by":"crossref","first-page":"453","DOI":"10.2147\/NSS.S162762","volume":"12","author":"EC Barker","year":"2020","unstructured":"Barker EC, Flygare J, Paruthi S, Sharkey KM. Living with narcolepsy: current management strategies, future prospects, and overlooked real-life concerns. Nat Sci Sleep. 2020;12:453\u201366.","journal-title":"Nat Sci Sleep."},{"key":"1142_CR30","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1136\/practneurol-2018-002001","volume":"19","author":"P Reading","year":"2019","unstructured":"Reading P. Cataplexy. Pract Neurol. 2019;19:21\u20137.","journal-title":"Pract Neurol"},{"key":"1142_CR31","doi-asserted-by":"crossref","unstructured":"Lavender M, Martin C, Anderson D. Sodium oxybate: practical considerations and patient perspectives. CNS Drugs. 2025. 10.1007\/s40263-024-01144-6","DOI":"10.1007\/s40263-024-01144-6"},{"key":"1142_CR32","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/nrneurol.2014.97","volume":"10","author":"Y Dauvilliers","year":"2014","unstructured":"Dauvilliers Y, Siegel JM, Lopez R, et al. Cataplexy-clinical aspects, pathophysiology and management strategy. Nat Rev Neurol. 2014;10:386\u201395.","journal-title":"Nat Rev Neurol"},{"key":"1142_CR33","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.2147\/NSS.S278046","volume":"13","author":"L Quaedackers","year":"2021","unstructured":"Quaedackers L, Pillen S, Overeem S. Recognizing the symptom spectrum of narcolepsy to improve timely diagnosis: a narrative review. Nat Sci Sleep. 2021;13:1083\u201396.","journal-title":"Nat Sci Sleep."},{"key":"1142_CR34","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.sleep.2005.04.006","volume":"6","author":"LE Krahn","year":"2005","unstructured":"Krahn LE. Reevaluating spells initially identified as cataplexy. Sleep Med. 2005;6:537\u201342.","journal-title":"Sleep Med"},{"key":"1142_CR35","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1093\/sleep\/30.12.1705","volume":"30","author":"TI Morgenthaler","year":"2007","unstructured":"Morgenthaler TI, Kapur VK, Brown T, et al. Practice parameters for the treatment of narcolepsy and other hypersomnias of central origin. Sleep. 2007;30:1705\u201311.","journal-title":"Sleep"},{"key":"1142_CR36","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1111\/ene.14888","volume":"28","author":"CLA Bassetti","year":"2021","unstructured":"Bassetti CLA, Kallweit U, Vignatelli L, et al. European guideline and expert statements on the management of narcolepsy in adults and children. Eur J Neurol. 2021;28:2815\u201330.","journal-title":"Eur J Neurol"},{"key":"1142_CR37","doi-asserted-by":"crossref","DOI":"10.1111\/jsr.13383","volume":"30","author":"R Tadrous","year":"2021","unstructured":"Tadrous R, O\u2019Rourke D, Mockler D, Broderick J. Health-related quality of life in narcolepsy: a systematic review and meta-analysis. J Sleep Res. 2021;30: e13383.","journal-title":"J Sleep Res"},{"key":"1142_CR38","doi-asserted-by":"crossref","first-page":"231","DOI":"10.2147\/NSS.S229105","volume":"11","author":"AS Almeneessier","year":"2019","unstructured":"Almeneessier AS, Alballa NS, Alsalman BH, et al. A 10-year longitudinal observational study of cataplexy in a cohort of narcolepsy type 1 patients. Nat Sci Sleep. 2019;11:231\u20139.","journal-title":"Nat Sci Sleep."}],"container-title":["CNS Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-024-01142-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40263-024-01142-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-024-01142-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,30]],"date-time":"2025-03-30T10:22:56Z","timestamp":1743330176000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40263-024-01142-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":38,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["1142"],"URL":"https:\/\/doi.org\/10.1007\/s40263-024-01142-8","relation":{},"ISSN":["1172-7047","1179-1934"],"issn-type":[{"value":"1172-7047","type":"print"},{"value":"1179-1934","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"26 November 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article has been published as part of a journal supplement wholly funded by Avadel Pharmaceuticals (Chesterfield, MO, USA). This study was funded by Avadel Pharmaceuticals. Avadel Pharmaceuticals was involved in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; and in the decision to submit the article for publication. Open access publication and publication costs were funded by Avadel Pharmaceuticals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"L.E.O. is a consultant to Harmony Biosciences and has served on advisory boards for Avadel Pharmaceuticals and Jazz Pharmaceuticals. A.M.M. has served as a consultant, speaker, and\/or on advisory boards for Avadel Pharmaceuticals, Eisai, Harmony Biosciences, Jazz Pharmaceuticals, Alkermes, and Takeda Pharmaceutical Co; has received grant funding from National Institutes of Health, UCB Pharmaceuticals, Jazz Pharmaceuticals, ResMed Foundation, Coverys Foundation, Harmony Biosciences, and Geisinger Health Plan; is the CEO of DAMM Good Sleep, LLC; and serves as an advisor for Neura Health and Floraworks. L.K. is a consultant for and\/or has served on advisory boards for Avadel Pharmaceuticals and Takeda and has received research funding from Takeda and Axsome Therapeutics. M.L. is a speaker or has received consulting fees for participation on advisory boards for Avadel Pharmaceuticals, Harmony Biosciences, and Jazz Pharmaceuticals. M.H. is a consultant to Avadel; has received compensation or honoraria from Alkermes, Axsome Therapeutics, Centessa Pharmaceuticals, and Harmony Biosciences; and is a member of the Sleep Consortium Advisory Board. D.C. and B.S. are employees of MyHealthTeam, which received funding to conduct the research. J.G. is an employee of Avadel Pharmaceuticals.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}},{"value":"This study qualified for institutional review board exemption through Advarra per the US Department of Health and Human Services regulations found at 45 CFR 46.104(d)(2).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Written informed consent was obtained from each respondent prior to beginning the survey.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The datasets generated during and\/or analyzed during the current study are available from the corresponding author on reasonable request.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data Availability"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability"}},{"value":"L.E.O.: writing\u2014review and editing, formal analysis. A.M.M.: writing\u2014review and editing, formal analysis. L.K.: writing\u2014review and editing, formal analysis. M.L.: writing\u2014review and editing, formal analysis. M.H.: writing\u2014review and editing, formal analysis. D.C.: data curation, writing\u2014review and editing, formal analysis. B.S: data curation, writing\u2014review and editing, formal analysis. J.G.: writing\u2014review and editing, formal analysis. All authors have read and approved the final submitted manuscript and have agreed to be accountable for the work.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author Contributions"}}]}}